Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entrada Therapeutics, Inc.

9.13
+0.19002.13%
Post-market: 9.600.4700+5.15%19:51 EDT
Volume:127.38K
Turnover:1.16M
Market Cap:343.24M
PE:5.43
High:9.27
Open:8.77
Low:8.69
Close:8.94
Loading ...
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities